Aurélie Névéol

Ilia Kuznetsov, Osama Mohammed Afzal, Koen Dercksen et al.

The number of scientific articles produced every year is growing rapidly. Providing quality control over them is crucial for scientists and, ultimately, for the public good. In modern science, this process is largely delegated to peer review -- a distributed procedure in which each submission is evaluated by several independent experts in the field. Peer review is widely used, yet it is hard, time-consuming, and prone to error. Since the artifacts involved in peer review -- manuscripts, reviews, discussions -- are largely text-based, Natural Language Processing has great potential to improve reviewing. As the emergence of large language models (LLMs) has enabled NLP assistance for many new tasks, the discussion on machine-assisted peer review is picking up the pace. Yet, where exactly is help needed, where can NLP help, and where should it stand aside? The goal of our paper is to provide a foundation for the future efforts in NLP for peer-reviewing assistance. We discuss peer review as a general process, exemplified by reviewing at AI conferences. We detail each step of the process from manuscript submission to camera-ready revision, and discuss the associated challenges and opportunities for NLP assistance, illustrated by existing work. We then turn to the big challenges in NLP for peer review as a whole, including data acquisition and licensing, operationalization and experimentation, and ethical issues. To help consolidate community efforts, we create a companion repository that aggregates key datasets pertaining to peer review. Finally, we issue a detailed call for action for the scientific community, NLP and AI researchers, policymakers, and funding bodies to help bring the research in NLP for peer review forward. We hope that our work will help set the agenda for research in machine-assisted scientific quality control in the age of AI, within the NLP community and beyond.

Lisa Raithel, Hui-Syuan Yeh, Shuntaro Yada et al.

User-generated data sources have gained significance in uncovering Adverse Drug Reactions (ADRs), with an increasing number of discussions occurring in the digital world. However, the existing clinical corpora predominantly revolve around scientific articles in English. This work presents a multilingual corpus of texts concerning ADRs gathered from diverse sources, including patient fora, social media, and clinical reports in German, French, and Japanese. Our corpus contains annotations covering 12 entity types, four attribute types, and 13 relation types. It contributes to the development of real-world multilingual language models for healthcare. We provide statistics to highlight certain challenges associated with the corpus and conduct preliminary experiments resulting in strong baselines for extracting entities and relations between these entities, both within and across languages.

Thibaut Fabacher, Erik-André Sauleau, Emmanuelle Arcay et al.

Objective: To evaluate the accuracy, computational cost and portability of a new Natural Language Processing (NLP) method for extracting medication information from clinical narratives. Materials and Methods: We propose an original transformer-based architecture for the extraction of entities and their relations pertaining to patients' medication regimen. First, we used this approach to train and evaluate a model on French clinical notes, using a newly annotated corpus from Hôpitaux Universitaires de Strasbourg. Second, the portability of the approach was assessed by conducting an evaluation on clinical documents in English from the 2018 n2c2 shared task. Information extraction accuracy and computational cost were assessed by comparison with an available method using transformers. Results: The proposed architecture achieves on the task of relation extraction itself performance that are competitive with the state-of-the-art on both French and English (F-measures 0.82 and 0.96 vs 0.81 and 0.95), but reduce the computational cost by 10. End-to-end (Named Entity recognition and Relation Extraction) F1 performance is 0.69 and 0.82 for French and English corpus. Discussion: While an existing system developed for English notes was deployed in a French hospital setting with reasonable effort, we found that an alternative architecture offered end-to-end drug information extraction with comparable extraction performance and lower computational impact for both French and English clinical text processing, respectively. Conclusion: The proposed architecture can be used to extract medication information from clinical text with high performance and low computational cost and consequently suits with usually limited hospital IT resources